by Devices and Pharma | Oct 27, 2026 | Cardiovascular, Device Warning Letters, Industry Information, Industry News, Inspections, Med-Devices, Products_Devices, QMSR, Quality Management System, US-FDA
Medical Device Warning Letter to Peter Schiff Enterprises Quality system violations dating back to 2011 Home About Consumer Medical Devices Pharma AI Regulatory Quality News Enforcement Alerts Innovation Contact Agency cites device classification disputes, inadequate...
by Devices and Pharma | Oct 27, 2026 | Biologics Warning Letters, Biologics-information, Stem Cells, US-FDA
Biologics Warning Letters Unapproved stem cell and placenta products Home About Consumer Medical Devices Pharma AI Regulatory Quality News Enforcement Alerts Innovation Contact FDA challenges claims that biological products can treat serious diseases without...
by Devices and Pharma | Oct 27, 2026 | Biologics Warning Letters, Biologics-information, Industry Information, Industry News, US-FDA
Biologics Warning Letters Claimed device classification not supported by intended use Home About Consumer Medical Devices Pharma AI Regulatory Quality News Enforcement Alerts Innovation Contact FDA’s warning letter to Tides Medical illustrates how a...
by Devices and Pharma | Oct 24, 2026 | Peptides, Pharmaceuticals
What to Know about FDA’s Revised Peptide Guidance Home About Consumer News Food and Beverage Supplements Cosmetics Regulatory Medical Devices Pharma Biologics Combination Products In Vitro Diagnostics Veterinary AI Quality QMSR Central News Enforcement Alerts...
by Devices and Pharma | Oct 23, 2026 | Peptides, Pharmaceuticals
The Regulatory Dilemma of Experimental Peptides Home About Consumer News Food and Beverage Supplements Cosmetics Regulatory Medical Devices Pharma Biologics Combination Products In Vitro Diagnostics Veterinary AI Quality QMSR Central News Enforcement Alerts Innovation...
